1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Therapeutic Biological Drugs to 2020

Therapeutic Biological Drugs to 2020

  • October 2014
  • -
  • Greystone Research Associates

In recent years, the number of biological drugs in development and reaching the marketplace has increased significantly. The clinical application of these drugs is sometimes limited by a lack of desirable attributes for adequate absorption or distribution. So it’s critical to formulate these drugs into safe, stable and efficacious delivery systems. Because these drugs face formidable enzymatic and penetration barriers when administered orally, peptide and protein drugs continue to be developed almost exclusively for parenteral administration. The growth of biological drug products is having a significant effect on the way drugs and devices are developed. Cooperation between device designers and drug developers is occurring much earlier in the drug development cycle, allowing device designs in many cases to be tailored to the bioavailability targets and pharmacokinetic profiles of specific drug therapies.

What you Will Learn
- What biological drugs are currently marketed, how are they positioned in the market, what are the device specifics, and who markets them?
- Who are the important biological drug suppliers, their manufacturing infrastructure and locations, their capabilities?
- What are the major factors driving biological drug demand?
- How important are drug developer-ecosystem partner relationships and what are the key alliances in the industry?
- What are the essential design factors, material selection issues, technologies and market development issues for biological drug products?
- How are biological drugs aligned with various drug classes and therapeutic markets?
- What are the significant economic, technology, and regulatory factors affecting biological drugs?

Table Of Contents

Therapeutic Biological Drugs to 2020
Summary of Contents
Executive Summary

Biological Therapeutics Market Dynamics

The Biological Therapeutics Market Space
Clinical Trials and Drug Approvals
The Competitive Landscape
Demographics, Managed Care and Growth
Risks and Opportunities

Formulating Biological Drugs

Formulation Strategies
Stability
Half?Life and Therapeutic Protocols
Immunogenicity
Biological Formulation Technologies
Post?translational Modification
Encapsulation Technologies
Sustained Release Formulations
Conjugation
Lyophilization
Dosing Frequency
Treatment Compliance

Protein Drugs: Drug Analysis and Competitive Positioning

Antibodies
Enzymes
Growth Factors
Hematopoietics
Hormones
Immune Modulators
Other Protein Therapy Classes

Biological Drug Therapeutic Markets - Market Data and Forecasts

Antivirals
Asthma
Autoimmunity
Cardiology
Hematopoietics
Hepatitis
Immunotherapeutics
Metabolic Diseases
Multiple Sclerosis
Osteoporosis
Oncology
Ophthalmology
Orphan Diseases

Company Profiles

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Bioinformatics Market by Sector (Molecular Medicine, Agriculture, Forensic, Animal, Research & Gene Therapy), Product (Sequencing Platforms, Knowledge Management & Data Analysis) & Application (Genomics, Proteomics & Metabolomics) - Global Forecast to 202

Bioinformatics Market by Sector (Molecular Medicine, Agriculture, Forensic, Animal, Research & Gene Therapy), Product (Sequencing Platforms, Knowledge Management & Data Analysis) & Application (Genomics, Proteomics & Metabolomics) - Global Forecast to 202

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global bioinformatics market is projected to reach USD 16.18 billion by 2021 from USD 6.21 billion in 2016, growing at a CAGR of 21.1% during the forecast period. In this report, the bioinformatics ...

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.